Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may harm male fertility and damage the reproductive system.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Thyroid function may influence hair loss after COVID-19.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

COVID-19 vaccination may trigger lupus in some people.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.